News | January 24, 2024
Aster DM Healthcare gets shareholders nod to separate the GCC business
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Subscribe To Our Newsletter & Stay Updated
